anticorpos contra fator de crescimento de nervo (ngf) com estabilidade in vivo intensificada

The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-...

Full description

Saved in:
Bibliographic Details
Main Authors WEI LIU, JERRY A. HALL, SANDEEP DUTTA, DUNCAN CASSON, JOHN POWELL, ANDREA BEST, MARK MAGINN
Format Patent
LanguagePortuguese
Published 29.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-NGF antibodies, nucleic acids encoding the NGF antibodies, host cells for expressing the NGF antibodies and methods of using the antibodies for treating NGF-related diseases or conditions are also provided.
AbstractList The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-NGF antibodies, nucleic acids encoding the NGF antibodies, host cells for expressing the NGF antibodies and methods of using the antibodies for treating NGF-related diseases or conditions are also provided.
Author SANDEEP DUTTA
WEI LIU
ANDREA BEST
DUNCAN CASSON
JERRY A. HALL
MARK MAGINN
JOHN POWELL
Author_xml – fullname: WEI LIU
– fullname: JERRY A. HALL
– fullname: SANDEEP DUTTA
– fullname: DUNCAN CASSON
– fullname: JOHN POWELL
– fullname: ANDREA BEST
– fullname: MARK MAGINN
BookMark eNqNijsKwkAQQLfQwt8dBistBKPxACqKdiKWQhh3Z2UgmQm7Q85vBA9g9Xi8N3YDUaGRe6IYe02tZvAqlhAimiYIBD5R9tyQmH5VKHUKC3nHZb82QNnwxTUH7CMLdNxnFiPJHNljwKkbRqwzzX6cuPn59DheVtRqRblFT0JWHe63a7EuyrLc7Tfbv6YPYTU-FQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID BRPI1014445A2
GroupedDBID EVB
ID FETCH-epo_espacenet_BRPI1014445A23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Portuguese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_BRPI1014445A23
Notes Application Number: BR2010PI14445
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161129&DB=EPODOC&CC=BR&NR=PI1014445A2
ParticipantIDs epo_espacenet_BRPI1014445A2
PublicationCentury 2000
PublicationDate 20161129
PublicationDateYYYYMMDD 2016-11-29
PublicationDate_xml – month: 11
  year: 2016
  text: 20161129
  day: 29
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies ABBOTT RESEARCH B.V
RelatedCompanies_xml – name: ABBOTT RESEARCH B.V
Score 3.0698197
Snippet The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title anticorpos contra fator de crescimento de nervo (ngf) com estabilidade in vivo intensificada
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161129&DB=EPODOC&locale=&CC=BR&NR=PI1014445A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DedijqVIFL0oUg_tz4UsV9MYVspU_YgjLRNpYhtWav-fS-x0z3tLcmFkFy4z9xdAK41Rg11YGRyouixrMe6JsdUS-QhUyyLMdMcxNyhP56Yo2f9aW7MO_C-yoURdUK_RXFEpKgE6b0R_Lr6d2J5IrayvotzHCrvg5ntSa11jOoLyi_Jc2w_nHpTV3Jd24mkSWSHj_xTWl03HpBfb3E9mhfa918cnpZSrcuUYB-2Q1yuaA6gUzU92HVXX6_1YGfcvnhjsyW--hBeEQl4b8uqrImIMKck4yYzSRlB3Q9lGff0lbxbIAcoyU3xlt3i1A-CrF9U0k0pAvOCfOUIzn-j1zOeVEKP4CrwZ-5Ixm0u_pCycKK1I2nH0C3Kgp0AUS2qUoNmmZaiMYK9xECDM1WSock0y7ROob9hobON0D7scRzzVDzVOodus_xkFyiTm_hS4PIH57eR-g
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8NADA9jivNNp6LOj0Ok6EOR9WvrQxHbrnS6L0qVPQjj2l6liG3Zqv775s5N97S3y6UcbUqS--WSHMC1yqiudPRUjttaJGuRpsoRVWO5y9qmyZhhdCIe0B-ODP9Ze5zq0xq8r2phRJ_Qb9EcETUqRn2vhL0u_4NYrsitXNxFGU4V915oudISHeP2Bf2X5NpWbzJ2x47kOJYdSKPAmvT5pbSapj-gvd7qICYUWOnF5mUp5bpP8fZge4LL5dU-1MqqCQ1ndfVaE3aGyxNvHC6Vb3EArygE_G_zslgQkWFOScohM0kYwb0f-jIe6Ss4maMFKMhN_pbe4qMfBE2_6KSbUGRmOfnKkJ39Zq-nvKiEHsKV1wsdX8bXnP0JZWYHa5-kHkE9L3J2DEQxqUJ1mqZqgmAEqVhHwJm0467BVNMwT6C1YaHTjdxLaPjhcDAb9EdPLdjl8uZleYp5BvVq_snO0T9X0YWQ6w_gbJTk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=anticorpos+contra+fator+de+crescimento+de+nervo+%28ngf%29+com+estabilidade+in+vivo+intensificada&rft.inventor=WEI+LIU&rft.inventor=JERRY+A.+HALL&rft.inventor=SANDEEP+DUTTA&rft.inventor=DUNCAN+CASSON&rft.inventor=JOHN+POWELL&rft.inventor=ANDREA+BEST&rft.inventor=MARK+MAGINN&rft.date=2016-11-29&rft.externalDBID=A2&rft.externalDocID=BRPI1014445A2